AIMN.US Lee Pharmaceuticals, Inc.
- Market cap
- USD 264K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is AIMN.US undervalued?
Graham numberThe Graham number of Lee Pharmaceuticals, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Lee Pharmaceuticals, Inc. fundamental analysis
No fundamental analysis for Lee Pharmaceuticals, Inc. yet.
Lee Pharmaceuticals, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Lee Pharmaceuticals, Inc.
Aimwell Partners Inc. develops healthcare intelligence, regulatory technology, and AI-driven verification infrastructure. The company provides source-verified intelligence systems, including regulatory monitoring, clinical intelligence, hallucination containment, and the Federated Health Intelligence Network for the biopharmaceutical and healthcare industries. Aimwell Partners Inc. was incorporated in 2013 and is headquartered in Mobile, Alabama.
Full company profileFinancial statements of Lee Pharmaceuticals, Inc. are not available yet.
Lee Pharmaceuticals, Inc. dividends
Lee Pharmaceuticals, Inc. has not paid dividends in the last 1 fiscal years.
Last stock split: 1:60000 on Mar 9, 2026.
Who owns Lee Pharmaceuticals, Inc.
Ownership data of Lee Pharmaceuticals, Inc. is not available yet.
Lee Pharmaceuticals, Inc. company profile
- Company name
- Lee Pharmaceuticals, Inc.
- Ticker
- AIMN.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Shell Companies
- Employees
- 1
- Fiscal year end
- December
- Address
- 11 N Water St, Mobile, AL, United States, 36602
- Phone
- 678-999-6242
- Website
- ronnmotorgroup.com
About Lee Pharmaceuticals, Inc.
Aimwell Partners Inc. develops healthcare intelligence, regulatory technology, and AI-driven verification infrastructure. The company provides source-verified intelligence systems, including regulatory monitoring, clinical intelligence, hallucination containment, and the Federated Health Intelligence Network for the biopharmaceutical and healthcare industries. Aimwell Partners Inc. was incorporated in 2013 and is headquartered in Mobile, Alabama.
Lee Pharmaceuticals, Inc. management
5- Mr. Ronal FordFounder, CEO & Chairman of the Board · born 1954
- Mr. C.G. RycheChief Branding & Marketing Officer · born 1970
- Dr. Delun WangSenior Vice President of Manufacturing & Engineering
- Mr. Damon KuhnChief Product Engineer & Product Manufacturing Integration · born 1964
- Ms. Sheila R. StewartChief Global Corporate Strategist